Photo taken from Hanneke Pouw/LinkedIn
Jun 11, 2024, 13:03
Hanneke Pouw: Tomorrow I’ll present our work in an oral presentation at the SNMMI24 in Toronto!
Hanneke Pouw, Amsterdam UMC, shared on LinkedIn:
“Tomorrow I’ll present our work in an oral presentation at the SNMMI24 in Toronto!
In this work supported by Boehringer Ingelheim we demonstrated Target Engagement and Saturating Effects in the Therapeutic Anti-SIRPα Antibody BI 765063 with quantitative immunoPET.
I’m really happy to have the opportunity to share our results and to connect with people in the field together with colleagues from the Amsterdam UMC and cancer center Amsterdam.
Session details: 10.35 – SS27 Oncology Basic: Preclinical and Early Clinical Development of Novel Radiopharmaceuticals.”
Source: Hanneke Pouw/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 14:05
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10